Mild clinical expression of myasthenia gravis associated with autoimmune thyroid diseases

被引:82
作者
Marino, M
Ricciardi, R
Pinchera, A
Barbesino, G
Manetti, L
Chiovato, L
Braverman, LE
Rossi, B
Muratorio, A
Mariotti, S
机构
[1] UNIV PISA, INST ENDOCRINOL, I-56018 TIRRENIA, ITALY
[2] UNIV PISA, INST NEUROL, I-56018 TIRRENIA, ITALY
[3] UNIV CAGLIARI, INST INTERNAL MED, CAGLIARI, ITALY
[4] UNIV MASSACHUSETTS, DIV ENDOCRINOL & METAB, WORCESTER, MA 01655 USA
关键词
D O I
10.1210/jc.82.2.438
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Myasthenia gravis (MG) may occur in association with autoimmune thyroid diseases (AITD). The aim of this study was to evaluate the features of MG associated with AITD compared to those of MG without AITD. A total of 129 MG patients (34 men and 95 women; age range, 11-81 yr) were subdivided into: group A, 56 MG patients with AITD [25 with autoimmune thyroiditis and 31 with Graves' disease (GD)I; group B, 21 MG patients with nonautoimmune thyroid diseases; and group C, 52 MG patients without thyroid disease. The severity of MG was ranked according to the Osserman score. Laboratory evaluation included assays for antithyroid and antiacetylcholine receptor (AchRAb) antibodies. Ocular MG (Osserman's class 1) was more frequent in group A (41.0%) than in group B (14.2%; P < 0.03) or C (21.4%; P < 0.03). Severe generalized MG (classes greater than or equal to 2B) was more frequent in groups B (57.1%; P < 0.03) and C (51.9%; P < 0.02) than in group A (28.5%). GD patients with clinical evidence of ophthalmopathy had a higher frequency (P = 0.05) of ocular MG (57.8%) than GD patients without clinical ophthalmopathy (16.6%). Thymic disease was less frequent in group A (26.7%) than in group B (71.4%; P = 0.001) or C (59.7%; P = 0.001). The prevalence of thymic hyperplasia was 17.8%, 38.0%, and 40.3% in groups A, B, and C, respectively; the prevalence of thymoma was 8.9%, 33.4%, and 19.4%. When only patients with generalized MG were considered, thymic disease was less frequent (P < 0.02) in group A (40.6%) than in the remaining groups (69.4%). AchRAb was more frequent in groups B (57.1%) and C (57.6%; P < 0.03) than in group A (35.7%). In conclusion, MG associated with AITD has a mild clinical expression, with preferential ocular involvement and lower frequency of thymic disease and AchRAb. This supports the hypothesis that ocular and generalized MG are separate diseases with different spectra of associated diseases. Nonautoimmune thyroid diseases have no influence on the features of MG. The association of ocular MG and AITD might be due to a common autoimmune mechanism and/or a peculiar genetic background.
引用
收藏
页码:438 / 443
页数:6
相关论文
共 55 条
[1]   MYASTHENIA-GRAVIS WITH THYMOMA IS NOT ASSOCIATED WITH AN INCREASED INCIDENCE OF NONMUSCLE AUTOIMMUNE DISORDERS [J].
AARLI, JA ;
GILHUS, NE ;
MATRE, R .
AUTOIMMUNITY, 1992, 11 (03) :159-162
[2]  
AGHINILOMBARDI F, 1993, NATO ADV SCI INST SE, V241, P403
[3]  
BACH JF, 1993, SPRINGER SEMIN IMMUN, V14, P239
[4]  
BARTOCCIONI E, 1986, LANCET, V1, P1038
[5]  
BRAVERMAN LE, 1991, WERNER INGBARS THYRO, P645
[6]   GRAVES OPHTHALMOPATHY - CURRENT CONCEPTS REGARDING PATHOGENESIS AND MANAGEMENT [J].
BURCH, HB ;
WARTOFSKY, L .
ENDOCRINE REVIEWS, 1993, 14 (06) :747-793
[7]   DETECTION OF ANTIBODIES BLOCKING THYROTROPIN EFFECT USING CHINESE-HAMSTER OVARY CELLS TRANSFECTED WITH THE CLONED HUMAN TSH RECEPTOR [J].
CHIOVATO, L ;
VITTI, P ;
BENDINELLI, G ;
SANTINI, F ;
FIORE, E ;
CAPACCIOLI, A ;
TONACCHERA, M ;
MAMMOLI, C ;
LUDGATE, M ;
PINCHERA, A .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1994, 17 (10) :809-816
[8]  
CHRISTENSEN PB, 1995, ACTA NEUROL SCAND, V91, P192
[9]   THE OFFICE TENSILON TEST FOR OCULAR MYASTHENIA-GRAVIS [J].
DAROFF, RB .
ARCHIVES OF NEUROLOGY, 1986, 43 (08) :843-844
[10]   MEDICAL PROGRESS - MYASTHENIA-GRAVIS [J].
DRACHMAN, DB .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (25) :1797-1810